Analysts think FBRX stock price could increase by 855%
May 10, 2025, 11:25 AM
76.35%
What does FBRX do
Forte Biosciences, a Dallas-based biopharmaceutical company, specializes in dermatology products and is advancing product candidate FB-102 for autoimmune diseases. The company went public on April 13, 2017, and holds a U.S. patent for skin treatment.
4 analysts think FBRX stock price will increase by 855.24%. The current median analyst target is $60.18 compared to a current stock price of $6.30. The lowest analysts target is $57.57 and the highest analyst target is $64.05.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.